Se connecter Inscription gratuite

Last updated: 14 June 2024 at 4:45pm EST

Michael Dybbs Net Worth



Michael Dybbs STRO stock SEC Form 4 insiders trading

Michael has made over 1 trades of the Sutro Biopharma Inc stock since 2015, according to the Form 4 filled with the SEC. Most recently he bought 961,538 units of STRO stock worth $12,499,994 on 27 October 2015.

The largest trade he's ever made was buying 961,538 units of Sutro Biopharma Inc stock on 27 October 2015 worth over $12,499,994. On average, Michael trades about 53,419 units every 0 days since 2015. As of 27 October 2015 he still owns at least 2,059,283 units of Sutro Biopharma Inc stock.

You can see the complete history of Michael Dybbs stock trades at the bottom of the page.





Michael Dybbs biography

Dr. Michael Dybbs, Ph.D. is an Independent Director of the Company. Dr. Dybbs is currently a partner at Samsara BioCapital, where he has worked since March 2017. Prior to joining Samsara, Dr. Dybbs was a partner at New Leaf Venture Partners, where he worked from May 2009 until September 2016. Before joining New Leaf Venture Partners, L.L.C., Dr. Dybbs was a principal at the Boston Consulting Group. Dr. Dybbs currently serves on the boards of directors of several private companies. Dr. Dybbs previously served on the boards of directors of Versartis, Inc. and Dimension Therapeutics, Inc. Dr. Dybbs received an A.B. in biochemical sciences from Harvard College and a Ph.D. in molecular biology from University of California, Berkeley, where he was awarded a Howard Hughes Medical Institute fellowship. Dybbs is qualified to serve on our Board of Directors due to his experience in the life sciences industry and the venture capital industry, and his leadership and management experience.

What is the salary of Michael Dybbs?

As the Independent Director of Sutro Biopharma Inc, the total compensation of Michael Dybbs at Sutro Biopharma Inc is $124,846. There are 11 executives at Sutro Biopharma Inc getting paid more, with William Newell having the highest compensation of $3,817,120.



How old is Michael Dybbs?

Michael Dybbs is 45, he's been the Independent Director of Sutro Biopharma Inc since 2018. There are 20 older and 1 younger executives at Sutro Biopharma Inc. The oldest executive at Sutro Biopharma Inc is Dr. Shabbir T. Anik, 68, who is the Chief Technical Operations Officer.

What's Michael Dybbs's mailing address?

Michael's mailing address filed with the SEC is C/O NKARTA, INC., 1150 VETERANS BOULEVARD, SOUTH SAN FRANCISCO, CA, 94080.

Insiders trading at Sutro Biopharma Inc

Over the last 6 years, insiders at Sutro Biopharma Inc have traded over $14,451,171 worth of Sutro Biopharma Inc stock and bought 750,858 units worth $10,652,478 . The most active insiders traders include Corp /De/ Celgene, John Gordon Freund et Daniel Janney. On average, Sutro Biopharma Inc executives and independent directors trade stock every 19 days with the average trade being worth of $129,762. The most recent stock trade was executed by Jane Chung on 9 August 2024, trading 18,750 units of STRO stock currently worth $86,438.



What does Sutro Biopharma Inc do?

at sutro biopharma we have pioneered a compelling and unique way of discovering, developing and manufacturing therapeutics. our focus is aimed primarily on next generation cancer therapeutics — antibody conjugates and bispecific antibodies. unconstrained by traditional methods of cell-based discovery, we can design and develop targeted medicines by innovating outside the constraints of the cell. our technology enables us to iteratively discover and test molecules in a rapid cycle of weeks rather than months, to rapidly identify the optimal molecule designed for safety and potency. our approach to discovery, without the cell, is also transcending the the limitations of biologics manufacturing. sutro has the world’s only cgmp cell-free manufacturing facility located in san carlos, california. this state-of- the-art facility confers an important competitive advantage as we head into human clinical trials in 2018. in addition to developing our own oncology pipeline, sutro biopharma is coll



What does Sutro Biopharma Inc's logo look like?

Sutro Biopharma Inc logo

Sutro Biopharma Inc executives and stock owners

Sutro Biopharma Inc executives and other stock owners filed with the SEC include: